Protein detail

LYPD3

Ly6/PLAUR domain-containing protein 3 (GPI-anchored metastasis-associated protein C4.4A homolog) (Matrigel-induced gene C4 protein) (MIG-C4)

Protein symbol
LYPD3
UniProt ID
EVMP score
0.25
Frequency
1
Transmembrane count
Protein classification
Predicted membrane proteins
Basic Information
Protein Names
Ly6/PLAUR domain-containing protein 3 (GPI-anchored metastasis-associated protein C4.4A homolog) (Matrigel-induced gene C4 protein) (MIG-C4)
Protein Class
Predicted membrane proteins
Entrez Gene Symbol
Gene Synonym
C4.4A
Gene Description
LY6/PLAUR domain containing 3
Chromosome
19
Position
43460787-43465608
Frequency
1
EVMP Score
0.25
Fluorescence & Localization
Tissue SpecificintestineCell SpecificCardiomyocytesSingle-Nuclei Brain Specificcommitted oligodendrocyte precursorBlood Cell Specificintermediate monocyteBlood Lineage Specificdendritic cells
Function & Pathway
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

22 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
transmembrane_phobiustransmembrane_predictedAlmen2009NoNoNoYesYes
transmembrane_sosuitransmembrane_predictedAlmen2009NoNoNoYesYes
Page 3 of 3Previous

Regulatory Interaction Network

0 records.

Protein Complex Composition

6 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
LYPD3O952742PDBPDB:6iom
LYPD3PEX11BPHTF1REEP1O95274O96011Q9H902Q9UMS50:0:0:0hu.MAP
DPY19L1LYPD3PHTF1REEP1O95274Q2PZI1Q9H902Q9UMS50:0:0:0hu.MAP
LYPD3PHTF1REEP1SLC41A1O95274Q8IVJ1Q9H902Q9UMS50:0:0:0hu.MAP
LYPD3PHTF1PHTF2REEP1O95274Q8N3S3Q9H902Q9UMS50:0:0:0hu.MAP
LYPD3PHTF1REEP1USP24O95274Q9H902Q9UMS5Q9UPU50:0:0:0hu.MAP

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass spectrometry;Western blotting24059637636573687
Sequence, Structure & Domains

Sequences

Length
346
Mass
35,971
Sequence
MDPARKAGAQAMIWTAGWLLLLLLRGGAQALECYSCVQKADDGCSPNKMKTVKCAPGVDVCTEAVGAVETIHGQFSLAVRGCGSGLPGKNDRGLDLHGLLAFIQLQQCAQDRCNAKLNLTSRALDPAGNESAYPPNGVECYSCVGLSREACQGTSPPVVSCYNASDHVYKGCFDGNVTLTAANVTVSLPVRGCVQDEFCTRDGVTGPGFTLSGSCCQGSRCNSDLRNKTYFSPRIPPLVRLPPPEPTTVASTTSVTTSTSAPVRPTSTTKPMPAPTSQTPRQGVEHEASRDEEPRLTGGAAGHQDRSNSGQYPAKGGPQQPHNKGCVAPTAGLAALLLAVAAGVLL

3D Structural Models

Turn
46..48; 148..150
Helix
164..166; 221..223
Beta Strand
32..42; 50..53; 61..70; 73..82; 87..96; 99..110; 139..141; 143..145; 158..160; 171..181; 184..195; 201..206; 209..216
3D Structure
X-ray crystallography (2)

Domain & Motif Annotations

Compositional Bias
234..246; Pro residues; 247..269; Low complexity; 283..295; Basic and acidic residues
Domain (FT)
33..126; UPAR/Ly6 1; 140..222; UPAR/Ly6 2
Region
233..324; Disordered
Clinical Relevance